Abstract

Type 1 diabetes remained one of the most challenging chronic conditions in adolescent populations, requiring 
meticulous glucose monitoring and management to prevent acute complications and long-term sequelae. The 
integration of continuous glucose monitoring systems with telemedicine platforms represented a paradigm shift in 
pediatric diabetes care, offering real-time data transmission and remote clinical oversight. This review examined the 
efficacy, implementation challenges, and clinical outcomes of telemedicine-facilitated continuous glucose monitoring 
in adolescents with type 1 diabetes, exploring how digital health technologies enhance metabolic control and quality 
of life. This review synthesized current evidence from clinical studies, systematic reviews, and expert consensus 
statements published between 2018 and 2024. Telemedicine integration with continuous glucose monitoring 
demonstrated significant improvements in glycemic control, reducing hemoglobin A1c levels by 0.4 to 0.8 percent, 
decreasing hypoglycemic events, and enhancing treatment adherence among adolescent patients. Remote 
monitoring facilitated timely interventions, reduced clinic visit frequency, and improved patient-provider 
communication while addressing barriers related to geographic distance and socioeconomic constraints. The 
synergistic application of telemedicine and continuous glucose monitoring technologies offered substantial benefits 
for adolescent type 1 diabetes management, though successful implementation required attention to technological 
literacy, data security, and equitable access.